Marcus-Yaffee-Flier
1 like123 views
Marcus Yaffee, PhD will present "Multimodal Imaging Probes For Research, Diagnostics and Therapeutics" on Tuesday, August 11th, 2015 from 4:00-5:00pm at the HMRI Research Conference Center located at 734 Fairmount Avenue in Pasadena, CA. The presentation will discuss the development and validation of new imaging probes for biomedical research and clinical applications, including the design and synthesis of modular biocompatible mixed-metal nanoparticle composites for multimodal imaging using PET/MRI/CT. Case studies demonstrating the function of imaging markers will be presented.
1 of 1
Download to read offline
![Multimodal Imaging
Probes For Research,
Diagnostics and
Therapeutics
Presented by:
Marcus Yaffee, PhD
MPH Professional
Senior Research Scientist
Translational Imaging, USC
When:
Tuesday, AUGUST 11th, 2015
4:00 5:00 p.m.
Where:
HMRI Research Conference Center
734 Fairmount Avenue
Pasadena, CA 91105
This activity has been planned and implemented in accordance with the
accreditation requirements and policies of the Institute for Medical
Quality/California Medical Association (IMQ/CMA) through the joint
providership of Huntington Hospital and Huntington Medical Research
Institutes. The Huntington Hospital is accredited by the IMQ/CMA to provide
continuing medical education for physicians.
Huntington Hospital designates this live activity for a maximum of 1 hour of
AMA PRA Category 1 Credit. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
TOPIC SUMMARY:
Development and validation of new imaging probes for
biomedical research and clinical applications; design and
synthesis of modular biocompatible mixed-metal
nanoparticle [MMNP] composites for mutli-modal
imaging. MMNP can be used for molecular targeted
imaging and therapies, e.g. PET/MRI/CT. In vitro, in situ
and in vivo case studies will be presented to
demonstrate the function of each class of marker.
ABOUT THE SPEAKER:
Marcus Yaffee studied Chemistry at UNM, USA and the
University of Cambridge, UK. He was awarded his PhD
from the Swiss Federal Institute of Technology, Zurich
and a professional MPH (Toxicology/EHS) at UC Berkeley
(2006). He was Senior Scientist, Nuclear Medicine,
University Hospital Bern, Switzerland (2012) , and is
currently a research scientist in the group of Prof. Scott
Fraser at the USC Translational Imaging Center. Dr.
Yaffees professional skillsets include Synthetic
Chemistry, Cell biology, Biophysics, Immunology and
Toxicology as well as their clinical application.
TARGET AUDIENCE: Clinicians and Researchers.
LEARNING OBJECTIVES:
1. Gain knowledge of state-of-the-art and next
generation imaging probes for diagnostics and
therapeutics.
2. Understand clinical applications of theranostic
probes.
3. Identify and design biomedical research studies
using multimodal probes.
4. Understand clinical application of multiplexed
probes in pathology.](https://image.slidesharecdn.com/d93537b5-ae31-4363-98bd-da0efc36e0d0-161222105200/85/Marcus-Yaffee-Flier-1-320.jpg)
Recommended
Journal of Nanomedicine & Biotherapeutic Discovery
Journal of Nanomedicine & Biotherapeutic DiscoveryOMICS International
油
OMICS Publishing Group, Journal of Nanomedicine & Biotherapeutic Discovery (JNBD) is an international, peer-reviewed journal. Each issue of Journal of Nanomedicine & Biotherapeutic Discovery presents basic, clinical, and engineering research in the field of nanomedicine and the related biotherapeutic discovery. The regular features addresses the commercialization of nanomedicine advances, ethics in nanomedicine, funding opportunities, and other topics of interest to researchers and clinicians.Clinical Trial Accrual Challenges: Is Social Media Here to Help? (A. Denicoff)
Clinical Trial Accrual Challenges: Is Social Media Here to Help? (A. Denicoff)Esmeralda Casas-Silva, Ph.D.
油
This document provides an overview of clinical trial accrual challenges and discusses how social media could potentially help address some of these challenges. It summarizes the National Clinical Trials Network (NCTN) and reviews major accrual barriers experienced by institutions, investigators, and patients. These include a lack of trial awareness, preference for standard care over trials, and concerns about side effects. The document then describes NCI's use of Twitter to promote NCTN trials and poses questions about how social media could enhance awareness of cancer clinical trials.March18 BEST agenda FINAL
March18 BEST agenda FINALRandy V. Clower, Ph.D., J.D.
油
This document describes the Broadening Experiences in Scientific Training (BEST) program at Cornell University. The BEST program provides graduate students and postdoctoral scholars opportunities to explore careers outside of academia through workshops, courses, externships and internships in areas like science communication, policy, industry, and management. It received $1.8 million in NIH funding over 5 years to support STEM students in gaining skills and experience relevant to diverse career paths. The document outlines the program's activities and goals to better prepare students for a wide range of future careers.Automated image analysis: rescue for diffusion-MRI of threat to radiologists?
Automated image analysis: rescue for diffusion-MRI of threat to radiologists?Erik R. Ranschaert, MD, PhD
油
Is the increasing availability of automated image analysis a possibility to strengthen the application of diffusion-MRI as a biometric parameter, and to enhance the future of image biobanks? Or is this evolution threatening the position of radiologists as medical doctors. Is a redefinition of radiologist as computer technicians inevitable? PBSS sf 10-28-2016 flyer
PBSS sf 10-28-2016 flyerVinita Gupta
油
This document announces a one-day symposium on biomarkers for immuno-oncology therapeutics to be held on October 28, 2016 in Foster City, CA. The symposium will introduce fundamentals, technologies, and applications of biomarkers in research, translational, and clinical development of immune-oncology treatments. Nine speakers from academia and biotech/pharma companies will present on topics such as maximizing anti-PD1 therapy, biomarker strategies for combination immunotherapy, biomarkers for novel checkpoint inhibitors, analysis of the tumor microenvironment, and prediction of tumor response to checkpoint inhibitors. The goal is for participants to learn the latest advancements and network with others in the field.JADA_News_Oct_2014
JADA_News_Oct_2014Janice Snider
油
Selective serotonin reuptake inhibitors (SSRIs), a common type of antidepressant, were found to be linked to an increased risk of dental implant failure according to a study of 490 patients. The study showed a failure rate of 10.6% for implants in patients taking SSRIs, compared to 4.6% for patients not taking them. A separate cost-effectiveness study of surgical treatments for trigeminal neuralgia found that percutaneous stereotaxic rhizotomy (PSR) was the most cost-effective at $600 per quality adjusted life year, though it was the least commonly performed procedure.Support & information for radiotherapy patients: how can social media help?
Support & information for radiotherapy patients: how can social media help?KimMeeking
油
際際滷s from my presentation looking at social media for patient benefit and also for healthcare professionals in the field of cancer and radiation therapy.
Presented at the UK Radiological and Radiation Oncology Congress (UKRCO), Liverpool, July 2nd 2018PMED: APPM Workshop: Data & Analytics in Precision Oncology- Warren Kibbe, Ma...
PMED: APPM Workshop: Data & Analytics in Precision Oncology- Warren Kibbe, Ma...The Statistical and Applied Mathematical Sciences Institute
油
This document discusses using data from the Veterans Affairs (VA) healthcare system to conduct precision oncology research. It describes extracting data from the VA Corporate Data Warehouse, including clinical records from cancer registries and records of patients who received tumor sequencing and immunotherapy. The author builds a cohort of 330 non-small cell lung cancer patients who received immunotherapy before 2018 and had their cancer verified in the registry to study outcomes like the impact of PD-L1 expression on response to treatment. Challenges include lag times in cancer registry reporting and building a large enough cohort to draw powerful conclusions from retrospective analyses.Moderators Report on Workshop on Wearable Biosensors in Clinical Trials
Moderators Report on Workshop on Wearable Biosensors in Clinical TrialsMarie Mc Carthy
油
- The workshop provided an overview of wearable biosensors and their potential uses in clinical trials from technology developers, users, and a regulatory perspective.
- While wearables can help quantify subjective outcomes, their technical quality is often less than medical devices, so their suitability depends on the study purpose.
- Wearables may help identify disease subcategories and bridge clinical trials and real-world experiences, but high standards are needed to establish diagnostic capabilities or influence regulatory views.Data Science in Drug Discovery
Data Science in Drug DiscoveryWrangleConf
油
Presenter: Marina Sirota, UCSF
Recent advances in genome typing and sequencing technologies have enabled quick generation of a vast amount of molecular data at very low cost. The mining and computational analysis of this type of data can help shape new diagnostic and therapeutic strategies in biomedicine. In this talk, I will discuss how such technological advances in combination with data science and integrative analysis can be applied to drug discovery in the context of drug target identification, computational drug repurposing, and population stratification approaches.Could this change how radiology residents record their clinical output?
Could this change how radiology residents record their clinical output?Apparao Mukkamala
油
Radiology residents around the world typically record experiential learning (EL) in a clinical logbook, but according to a new study published in the Journal of Digital Imaging, modern PACS and RIS technology could very well be used to build the EL portfolios of the future. https://www.radiologybusiness.com/topics/imaging-informatics/pacs-ris-radiology-residents-clinical-outputCellular Pathology Assignment
Cellular Pathology AssignmentTeresa Briercliffe
油
This document outlines an assignment on the cellular pathology of tuberculosis (TB). It includes the following:
1) The purpose is for students to examine how cellular pathology can be used to diagnose, determine treatment, and monitor TB progression by comparing normal and diseased structures.
2) The task is to define cellular pathology and describe how various TB tests (e.g. Mantoux testing, chest x-rays, sputum samples) are used to identify latent vs. active TB at the cellular level.
3) An additional task is to write a 1,000-word essay discussing the link between the biochemistry of the respiratory system and how biochemical malfunctions cause TB progression. JournalofCancerEpidemiologyandTreatment3
JournalofCancerEpidemiologyandTreatment3Christian Schmidt
油
The document discusses how technology has helped shed light on cancer through research using large facilities like synchrotron radiation and neutron laboratories. Over 100,000 protein structures have been determined using these techniques to better understand biochemical processes and design drugs. Countries are investing in new facilities to advance scientific development and tackle challenges like cancer. Nanotechnology and drug delivery systems combined with characterization techniques can improve cancer treatment methods.The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...jangeissler
油
This document discusses the benefits of patient involvement in health research and development. It notes that innovation is transforming lives but more breakthroughs are still needed. Patients can provide unique perspectives to improve trial design and address unmet needs. However, public distrust and lack of knowledge limit patient participation in research. The document advocates for greater patient involvement at all stages of research, from setting priorities to disseminating results. It highlights the EUPATI initiative which aims to educate patients and the public about medicines research through training courses, educational tools, and national platforms. The goal is empowering patients as partners in research.Reflexion on lisandra
Reflexion on lisandraeduardo2324
油
Lisandra, a fellow student studying for her PhD in chemistry, discussed a review paper on proteomics biomarker discovery with Eduardo Rivera Cintron and other students. The paper explained that discovering biomarkers requires more than just mass spectrometry. Biomarkers could enable earlier disease diagnosis and improved treatment. New proteomics technologies developed over the past decade, such as shotgun proteomics, plasma/tissue analysis, and cell-based assays, have intensified the search for biomarkers. Lisandra emphasized the importance of biomarkers for medicine and the benefits they could provide through earlier disease detection.InnVentis Precision Medicine 2014
InnVentis Precision Medicine 2014Thomas Wilckens
油
Precision medicine represents a shift from symptom-based and intuition-based medicine of the past to a data-driven approach using an individual's molecular and genomic data to guide prevention, diagnosis, and treatment decisions. By applying rules, algorithms and reference databases to integrate multiple types of data such as molecular fingerprints, imaging, and non-molecular content, precision medicine enables actionable clinical decision support and precise, efficient care tailored to each individual.Using side effects for drug target identification
Using side effects for drug target identificationLars Juhl Jensen
油
The document discusses using drug side effects to identify new drug targets. It describes extracting information on side effects from package inserts and text mining, then correlating side effect profiles with chemical structures to find similar drugs that may share targets. The approach successfully predicted targets for 20 drug pairs, with 11 showing in vitro binding and 9 affecting cells as predicted. Future work involves directly linking side effects to targets and target prediction without known targets.The Impact of Medical Technology on Healthcare today
The Impact of Medical Technology on Healthcare todayJeanneRoseDacallos
油
Rapid advances in medical technology have revolutionized healthcare delivery. New diagnostic and treatment technologies have improved accuracy and outcomes compared to past experimentation. Centralization of patient data through technology has enhanced quality. While expensive, medical technology provides health benefits and economic value by improving lives and productivity. The benefits of medical advancements outweigh potential drawbacks if they can improve quality of life and health outcomes cost-effectively.Reflexion on lisandra
Reflexion on lisandraeduardo2324
油
Lisandra, a fellow student studying for her PhD at the University of Buffalo, discussed a review paper titled "Proteomics biomaker discovery: It's more than mass spectrometry" with Eduardo Rivera Cintron and other students. The paper argues that discovering biomarkers requires more than just mass spectrometry and that biomarkers could enable earlier disease diagnosis and improved treatment. It also describes new proteomics technologies developed in recent decades like shotgun proteomics and plasma/tissue analysis that have aided biomarker discovery. However, the biomarker validation process is complex and typically only reaches the qualification step.Text and data mining
Text and data miningLars Juhl Jensen
油
The document discusses text and data mining techniques for analyzing biomedical literature and datasets. It describes using text mining to extract named entities and build protein interaction networks by identifying relationships between genes. It also discusses using text mining of drug side effect descriptions to discover new relationships between existing drugs and predict potential new uses and targets for drugs.Chapter 1. Introduction
Chapter 1. Introductionbutest
油
The document discusses the exponential growth of biomedical research data and literature. It describes challenges researchers face in keeping up with the vast amount of information. Text mining techniques can help by automatically extracting relevant information and facts from literature and organizing them into structured knowledgebases. Named entity recognition is an important text mining task that involves identifying mentions of biomedical entities in text. Both rule-based and machine learning approaches have been used for named entity recognition.The role of patients and healthcare providers in translational medicine
The role of patients and healthcare providers in translational medicinejangeissler
油
The role of patients and healthcare providers in translational medicine, presented by Jan Geissler at the European Commission's Personalized Medicine Conference 2016 on 1 June 2016 in BrusselsRahul Resume - RA CV
Rahul Resume - RA CVrahul gunasekera
油
Rahul Gunasekera has over 5 years of experience in clinical research and laboratory work. He currently coordinates clinical drug trials to satisfy regulatory standards as a clinical research coordinator. Previously, he worked as a surgical/histological technician processing tissue samples and training medical residents. In school, he conducted experiments in immunology and assisted researchers, developing skills in microscopy, cell culture, and molecular biology techniques.INFO90001 eHealth & biomedical Informatics tools & methods flyer
INFO90001 eHealth & biomedical Informatics tools & methods flyerHealth and Biomedical Informatics Centre @ The University of Melbourne
油
Flyer for the second elective Masters level subject in eHealth & HBI. Enrolments close on 31st August 2012.CV V2
CV V2Andy Goh
油
Andy Goh has extensive experience working in laboratories. He has conducted research on neuronal cell cultures and imaging at the Mitochondrial Research Group. Additionally, he has experience maintaining cell cultures and performing laboratory procedures at the Institute for Cell and Molecular Biosciences. Goh obtained a 2:1 BSc in Biomedical Sciences, achieving high marks in subjects including biochemistry, pharmacology, and cell biology. He has strong computer and laboratory skills including using imaging software and performing PCR.Information Visualization in Medical Informatics
Information Visualization in Medical InformaticsUniversity of Maryland
油
This document discusses information visualization research in medical informatics conducted by Ben Shneiderman and the Human-Computer Interaction Lab at the University of Maryland. The lab conducts interdisciplinary research using information visualization techniques to analyze medical data and patient histories. Examples of projects discussed include Spotfire for analyzing retinol and birth data, LifeLines for visualizing patient histories, LifeFlow for temporal data aggregation, and tools developed for the Strategic Health IT Advanced Research Projects program.air scruber
air scruberlindasahak
油
This document outlines a study assessing the awareness level of radiation safety among medical radiation workers. The study will survey radiation workers at two hospitals to determine their knowledge of radiation hazards and adherence to safety procedures. It will analyze factors that may influence awareness, such as training received. The results could help identify weaknesses and improve safety compliance. The findings may also promote greater awareness of radiation safety in occupational health fields.NIH Data Science Special Interest Group
NIH Data Science Special Interest GroupYaffa Rubinstien
油
The document discusses issues related to building sustainable biobanks. It outlines key factors for biobanks including having a clear purpose that determines their potential for generating knowledge, obtaining sufficient funding, and having a mandate and governance structure. It also stresses the importance of measuring success not just by the number of samples collected but by whether the biobank has accelerated research and discovery. The document uses the example of the Tumour Bank at the Children's Hospital at Westmead, which has supported over 90 projects, contributed samples to studies worldwide, and resulted in numerous publications despite being a small single-institution biobank.Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Clas...
Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Clas...James W
油
The success of these targeted therapies in the liver cancer market and oncology market as a whole shows that the innovation and diversity in the pipeline is a promising sign. It also shows that currently the products in pipeline possess the potential to transcend and enhance the relatively open liver cancer market.cv2
cv2michael taylor
油
Michael Taylor is currently studying for a BSc in games design at the University of Bolton. He has skills in programming, games design, 3D modeling, and narrative writing. He has worked on testing games like Heroes of the Storm and Hearthstone. Additionally, he has worked at a care home and game retail store to gain experience in roles like maintenance, sales, and stocking. His education has included modules in sound design, mechanics, and level design. In his personal time, he enjoys playing, researching, and attending events related to games and comics.More Related Content
What's hot (20)
Moderators Report on Workshop on Wearable Biosensors in Clinical Trials
Moderators Report on Workshop on Wearable Biosensors in Clinical TrialsMarie Mc Carthy
油
- The workshop provided an overview of wearable biosensors and their potential uses in clinical trials from technology developers, users, and a regulatory perspective.
- While wearables can help quantify subjective outcomes, their technical quality is often less than medical devices, so their suitability depends on the study purpose.
- Wearables may help identify disease subcategories and bridge clinical trials and real-world experiences, but high standards are needed to establish diagnostic capabilities or influence regulatory views.Data Science in Drug Discovery
Data Science in Drug DiscoveryWrangleConf
油
Presenter: Marina Sirota, UCSF
Recent advances in genome typing and sequencing technologies have enabled quick generation of a vast amount of molecular data at very low cost. The mining and computational analysis of this type of data can help shape new diagnostic and therapeutic strategies in biomedicine. In this talk, I will discuss how such technological advances in combination with data science and integrative analysis can be applied to drug discovery in the context of drug target identification, computational drug repurposing, and population stratification approaches.Could this change how radiology residents record their clinical output?
Could this change how radiology residents record their clinical output?Apparao Mukkamala
油
Radiology residents around the world typically record experiential learning (EL) in a clinical logbook, but according to a new study published in the Journal of Digital Imaging, modern PACS and RIS technology could very well be used to build the EL portfolios of the future. https://www.radiologybusiness.com/topics/imaging-informatics/pacs-ris-radiology-residents-clinical-outputCellular Pathology Assignment
Cellular Pathology AssignmentTeresa Briercliffe
油
This document outlines an assignment on the cellular pathology of tuberculosis (TB). It includes the following:
1) The purpose is for students to examine how cellular pathology can be used to diagnose, determine treatment, and monitor TB progression by comparing normal and diseased structures.
2) The task is to define cellular pathology and describe how various TB tests (e.g. Mantoux testing, chest x-rays, sputum samples) are used to identify latent vs. active TB at the cellular level.
3) An additional task is to write a 1,000-word essay discussing the link between the biochemistry of the respiratory system and how biochemical malfunctions cause TB progression. JournalofCancerEpidemiologyandTreatment3
JournalofCancerEpidemiologyandTreatment3Christian Schmidt
油
The document discusses how technology has helped shed light on cancer through research using large facilities like synchrotron radiation and neutron laboratories. Over 100,000 protein structures have been determined using these techniques to better understand biochemical processes and design drugs. Countries are investing in new facilities to advance scientific development and tackle challenges like cancer. Nanotechnology and drug delivery systems combined with characterization techniques can improve cancer treatment methods.The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...jangeissler
油
This document discusses the benefits of patient involvement in health research and development. It notes that innovation is transforming lives but more breakthroughs are still needed. Patients can provide unique perspectives to improve trial design and address unmet needs. However, public distrust and lack of knowledge limit patient participation in research. The document advocates for greater patient involvement at all stages of research, from setting priorities to disseminating results. It highlights the EUPATI initiative which aims to educate patients and the public about medicines research through training courses, educational tools, and national platforms. The goal is empowering patients as partners in research.Reflexion on lisandra
Reflexion on lisandraeduardo2324
油
Lisandra, a fellow student studying for her PhD in chemistry, discussed a review paper on proteomics biomarker discovery with Eduardo Rivera Cintron and other students. The paper explained that discovering biomarkers requires more than just mass spectrometry. Biomarkers could enable earlier disease diagnosis and improved treatment. New proteomics technologies developed over the past decade, such as shotgun proteomics, plasma/tissue analysis, and cell-based assays, have intensified the search for biomarkers. Lisandra emphasized the importance of biomarkers for medicine and the benefits they could provide through earlier disease detection.InnVentis Precision Medicine 2014
InnVentis Precision Medicine 2014Thomas Wilckens
油
Precision medicine represents a shift from symptom-based and intuition-based medicine of the past to a data-driven approach using an individual's molecular and genomic data to guide prevention, diagnosis, and treatment decisions. By applying rules, algorithms and reference databases to integrate multiple types of data such as molecular fingerprints, imaging, and non-molecular content, precision medicine enables actionable clinical decision support and precise, efficient care tailored to each individual.Using side effects for drug target identification
Using side effects for drug target identificationLars Juhl Jensen
油
The document discusses using drug side effects to identify new drug targets. It describes extracting information on side effects from package inserts and text mining, then correlating side effect profiles with chemical structures to find similar drugs that may share targets. The approach successfully predicted targets for 20 drug pairs, with 11 showing in vitro binding and 9 affecting cells as predicted. Future work involves directly linking side effects to targets and target prediction without known targets.The Impact of Medical Technology on Healthcare today
The Impact of Medical Technology on Healthcare todayJeanneRoseDacallos
油
Rapid advances in medical technology have revolutionized healthcare delivery. New diagnostic and treatment technologies have improved accuracy and outcomes compared to past experimentation. Centralization of patient data through technology has enhanced quality. While expensive, medical technology provides health benefits and economic value by improving lives and productivity. The benefits of medical advancements outweigh potential drawbacks if they can improve quality of life and health outcomes cost-effectively.Reflexion on lisandra
Reflexion on lisandraeduardo2324
油
Lisandra, a fellow student studying for her PhD at the University of Buffalo, discussed a review paper titled "Proteomics biomaker discovery: It's more than mass spectrometry" with Eduardo Rivera Cintron and other students. The paper argues that discovering biomarkers requires more than just mass spectrometry and that biomarkers could enable earlier disease diagnosis and improved treatment. It also describes new proteomics technologies developed in recent decades like shotgun proteomics and plasma/tissue analysis that have aided biomarker discovery. However, the biomarker validation process is complex and typically only reaches the qualification step.Text and data mining
Text and data miningLars Juhl Jensen
油
The document discusses text and data mining techniques for analyzing biomedical literature and datasets. It describes using text mining to extract named entities and build protein interaction networks by identifying relationships between genes. It also discusses using text mining of drug side effect descriptions to discover new relationships between existing drugs and predict potential new uses and targets for drugs.Chapter 1. Introduction
Chapter 1. Introductionbutest
油
The document discusses the exponential growth of biomedical research data and literature. It describes challenges researchers face in keeping up with the vast amount of information. Text mining techniques can help by automatically extracting relevant information and facts from literature and organizing them into structured knowledgebases. Named entity recognition is an important text mining task that involves identifying mentions of biomedical entities in text. Both rule-based and machine learning approaches have been used for named entity recognition.The role of patients and healthcare providers in translational medicine
The role of patients and healthcare providers in translational medicinejangeissler
油
The role of patients and healthcare providers in translational medicine, presented by Jan Geissler at the European Commission's Personalized Medicine Conference 2016 on 1 June 2016 in BrusselsRahul Resume - RA CV
Rahul Resume - RA CVrahul gunasekera
油
Rahul Gunasekera has over 5 years of experience in clinical research and laboratory work. He currently coordinates clinical drug trials to satisfy regulatory standards as a clinical research coordinator. Previously, he worked as a surgical/histological technician processing tissue samples and training medical residents. In school, he conducted experiments in immunology and assisted researchers, developing skills in microscopy, cell culture, and molecular biology techniques.INFO90001 eHealth & biomedical Informatics tools & methods flyer
INFO90001 eHealth & biomedical Informatics tools & methods flyerHealth and Biomedical Informatics Centre @ The University of Melbourne
油
Flyer for the second elective Masters level subject in eHealth & HBI. Enrolments close on 31st August 2012.CV V2
CV V2Andy Goh
油
Andy Goh has extensive experience working in laboratories. He has conducted research on neuronal cell cultures and imaging at the Mitochondrial Research Group. Additionally, he has experience maintaining cell cultures and performing laboratory procedures at the Institute for Cell and Molecular Biosciences. Goh obtained a 2:1 BSc in Biomedical Sciences, achieving high marks in subjects including biochemistry, pharmacology, and cell biology. He has strong computer and laboratory skills including using imaging software and performing PCR.Information Visualization in Medical Informatics
Information Visualization in Medical InformaticsUniversity of Maryland
油
This document discusses information visualization research in medical informatics conducted by Ben Shneiderman and the Human-Computer Interaction Lab at the University of Maryland. The lab conducts interdisciplinary research using information visualization techniques to analyze medical data and patient histories. Examples of projects discussed include Spotfire for analyzing retinol and birth data, LifeLines for visualizing patient histories, LifeFlow for temporal data aggregation, and tools developed for the Strategic Health IT Advanced Research Projects program.air scruber
air scruberlindasahak
油
This document outlines a study assessing the awareness level of radiation safety among medical radiation workers. The study will survey radiation workers at two hospitals to determine their knowledge of radiation hazards and adherence to safety procedures. It will analyze factors that may influence awareness, such as training received. The results could help identify weaknesses and improve safety compliance. The findings may also promote greater awareness of radiation safety in occupational health fields.NIH Data Science Special Interest Group
NIH Data Science Special Interest GroupYaffa Rubinstien
油
The document discusses issues related to building sustainable biobanks. It outlines key factors for biobanks including having a clear purpose that determines their potential for generating knowledge, obtaining sufficient funding, and having a mandate and governance structure. It also stresses the importance of measuring success not just by the number of samples collected but by whether the biobank has accelerated research and discovery. The document uses the example of the Tumour Bank at the Children's Hospital at Westmead, which has supported over 90 projects, contributed samples to studies worldwide, and resulted in numerous publications despite being a small single-institution biobank.INFO90001 eHealth & biomedical Informatics tools & methods flyer
INFO90001 eHealth & biomedical Informatics tools & methods flyerHealth and Biomedical Informatics Centre @ The University of Melbourne
油
Viewers also liked (11)
Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Clas...
Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Clas...James W
油
The success of these targeted therapies in the liver cancer market and oncology market as a whole shows that the innovation and diversity in the pipeline is a promising sign. It also shows that currently the products in pipeline possess the potential to transcend and enhance the relatively open liver cancer market.cv2
cv2michael taylor
油
Michael Taylor is currently studying for a BSc in games design at the University of Bolton. He has skills in programming, games design, 3D modeling, and narrative writing. He has worked on testing games like Heroes of the Storm and Hearthstone. Additionally, he has worked at a care home and game retail store to gain experience in roles like maintenance, sales, and stocking. His education has included modules in sound design, mechanics, and level design. In his personal time, he enjoys playing, researching, and attending events related to games and comics.Exposicion 1
Exposicion 1Edward Freire
油
The document discusses the use of prepositions after adjectives. It explains that the prepositions "about" and "at" are used after adjectives when there is a complement. For example, saying "excited about having a baby." It also notes that the "-ing" form of a verb is used when expressing an action after a preposition, like "excited about having." Finally, it provides examples of adjectives used correctly and incorrectly with "about" and "at."
SMI Oncology Imaging Aviesan Technology Transfer
SMI Oncology Imaging Aviesan Technology TransferNutopya Life Science
油
The document discusses imaging agent innovation challenges in France and the role of AVIESAN in addressing them. AVIESAN coordinates national research efforts, provides infrastructure like imaging platforms, and unites academic and industry actors through dedicated processes and clusters to translate imaging agents from discovery to clinical use. This is done by identifying unmet medical needs, supporting early clinical trials, and facilitating partnerships between researchers, SMEs, diagnostic and pharmaceutical companies.Molecular imaging a new field for a new world By Zaver M. Bhujwalla
Molecular imaging a new field for a new world By Zaver M. BhujwallaMolecular Imaging Society of India (MISI)
油
Molecular imaging has revolutionized our perceptions of imaging. This high impact field is finding transformative applications in the understanding, detection, and treatment of nearly all diseases.
The field of molecular imaging is a an exciting fusion and integration of many different disciplines including molecular biology, chemistry and probe design, imaging technologies, visualization, and image analysis, that are focused on understanding, detecting, and treating oncological, neurological, cardiovascular, inflammatory, metabolic, and infectious diseases. Based on their strengths, different imaging modalities provide different but equally valuable information that can be integrated in advancing our understanding of these diseases.
As the era of omics progresses towards personalized medicine, the field of molecular imaging is finding multiple uses in noninvasive characterization of the molecular features of diseases and their impact on function. In complex diseases such as cancer, with its tremendous genetic diversity, it is becoming increasingly important to develop molecularly-targeted treatment strategies that combine detection with treatment.
Theranostics: basic concepts and internal dosimetryTadeu Kubo
油
Theranostics: basic concepts and internal dosimetry. Lu-177, Y-90, Ga-68, Ra-223, MIRD 16, MIRD 23, MIRD 24.Theranostics
TheranosticsGanesh Kumar
油
Theranostics involves using radiolabeled agents for both diagnosing and treating diseases. Iodine-131 was one of the first theranostic agents used for both imaging and treating thyroid conditions. Other promising theranostic nuclides discussed include iodine-123, iodine-124, gallium-68, lutetium-177, copper-64, copper-67, tin-117m, and fluorine-18 FDG which shows potential for imaging and cytotoxic effects against cancer cells. Effective theranostic agents require properties like appropriate half-lives and radiation types to enable both diagnostic imaging and therapeutic doses to diseased sites.English for First class
English for First classPadma Lalitha
油
Ammu is a little girl who goes to school with her family which includes her mother, father, brother, grandparents, and sister. She takes the bus to school with her squirrel friend Bittu. At school, Ammu learns with her classmates and teacher. She enjoys activities like reading, playing, and eating. Ammu teaches Bittu good habits at home like brushing teeth and going to school. On the weekends, Ammu's family takes her to the zoo where she sees animals and makes a new friend. Ammu also goes to the market and learns about healthy foods.SPECT/PET Scans
SPECT/PET Scansrlmillerkatie
油
PET scans use radioactive tracers and positron emission tomography to create 3D images of processes in the body. A PET scan injects a radioactive tracer into the bloodstream which is detected as it undergoes positron emission. This allows PET scans to detect cancer, diagnose Alzheimer's disease early, and determine if bypass surgery would be effective. Possible side effects include injection site soreness and allergic reactions to the tracer. SPECT scans also use radioactive tracers but detect blood flow through the body. SPECT scans emit less radiation than PET scans or CT scans and are commonly used for pre-surgical evaluations and detecting reduced blood flow or tumors.SPECT
SPECTDavid Graff
油
Tomography involves measuring gamma ray attenuation along lines of sight at different angles in order to reconstruct the internal structure of an object. Filtered back projection enhances edges in the projection data through filtering and backprojects the filtered data to form an image. Iterative reconstruction accounts for physical factors like attenuation, scatter, and noise by comparing projections of a patient model to actual data and updating the model. Quality control ensures proper system operation through tests of the center of rotation, uniformity, and ability to detect small objects.Molecular imaging a new field for a new world By Zaver M. Bhujwalla
Molecular imaging a new field for a new world By Zaver M. BhujwallaMolecular Imaging Society of India (MISI)
油
Similar to Marcus-Yaffee-Flier (20)
Dr. Andre Mitchell's CV
Dr. Andre Mitchell's CVANDRE MITCHELL, M.D.
油
This document provides biographical information on Dr. Andre L. Mitchell including his education, training, employment history, affiliations, and research experience. He received his MD from the University of Missouri-Columbia School of Medicine and has since served in various roles including founder and CEO of Mitchell Global Holdings, radiation oncologist, and medical director. His experience includes clinical trials research with the Radiation Therapy Oncology Group and he maintains active medical licenses in Minnesota and Florida.Dr. Andre Mitchell's CV
Dr. Andre Mitchell's CVANDRE MITCHELL, M.D.
油
This document provides biographical information on Dr. Andre L. Mitchell including his education, training, employment history, affiliations, and research experience. He received his MD from the University of Missouri-Columbia School of Medicine and has since served in various roles including founder and CEO of Mitchell Global Holdings, radiation oncologist, and medical director. His experience includes clinical trials research with the Radiation Therapy Oncology Group and leadership positions with Coborn Cancer Center.UNC Eshelman School of Pharmacy Highlights
UNC Eshelman School of Pharmacy HighlightsUNC Eshelman School of Pharmacy
油
The document describes the UNC Eshelman School of Pharmacy as a recognized leader in pharmacy education, practice, and research. It provides details on its academic programs, research centers focused on drug discovery and development, and partnerships within UNC and with outside organizations. The School has over 100 faculty conducting research across therapeutic areas from discovery through clinical practice, and seeks to enhance its research enterprise through partnerships with industry.Big Data & Immunotherapeutics Symposium Program
Big Data & Immunotherapeutics Symposium ProgramMichael Evtushenko
油
This document provides an agenda and program details for a symposium on advances in childhood cancer hosted by Kids Cancer Alliance (KCA). The free event will be held on August 31, 2018 at the Australian National Maritime Museum and will feature talks on topics such as clinical application of whole genome sequencing, analysis of big data in pediatric cancers, cancer epigenetics, immunotherapies including CAR T cell therapy, and high dimensional analysis of single cell proteome data. Speakers include researchers from Australia, the US, and Switzerland with expertise in areas like cancer genomics, bioinformatics, immunology, and data science.iOncologi_Pitch Deck_2024 slide show for hostinger
iOncologi_Pitch Deck_2024 slide show for hostingerssuser9354ce
油
iOncologi is developing novel cancer immunotherapies including stem cell therapies and mRNA-nanoparticle vaccines. Their stem cell therapy has shown ability to overcome resistance to immune checkpoint inhibitors in preclinical studies and received FDA approval for clinical trials in glioblastoma patients. Their mRNA-NP vaccine platform is in early phase clinical trials for refractory solid cancers. iOncologi seeks capital to further clinical evaluation and develop allogeneic 'off-the-shelf' stem cell therapies.Swaan
SwaanUniversity of Maryland Baltimore
油
The document describes the Center of Cancer Nanotechnology Excellence (CCNE) at the University of Maryland. CCNEs link physical scientists and engineers working at the nanoscale with cancer biologists and oncologists to enable multi-disciplinary research on cancer-oriented nanotechnology. The Maryland CCNE will focus on pancreatic and lung cancer, with projects including targeted drug delivery using silicon nanotubes, surfactant nanovesicles, and magnetic particles. The center will have cores for translational research, bioinformatics, and analytical characterization. It will evaluate vitamin-targeted nanoparticles for chemotherapy delivery, having shown riboflavin receptors are upregulated in breast cancer cells and may enable targeted delivery.Functional Analysis & Screening Technologies Congress
Functional Analysis & Screening Technologies CongressJames Prudhomme
油
Join us in Boston this coming Fall to attend Cambridge Healthtech Institute's (CHI) 2nd Annual FAST: Functional Analysis & Screening Technologies Congress on November 17-19, 2014 and meet with a community of 250+ biologists, screening managers, assay developers, engineers and pharmacologists dedicated to improving in vitro cell models and phenotypic screening to advance drug discovery and development at 6 conferences: Phenotypic Drug Discovery (Part I & II), Engineering Functional 3D Models, Screening and Functional Analysis of 3D Models, Organotypic Culture Models for Toxicology and Physiologically-Relevant Cellular Tumor Models for Drug Discovery. Delegates have the opportunity to share insights in interactive panel discussions and connect during networking breaks. View innovative technologies and scientific research revolutionizing early-stage drug discovery in the exhibit/poster hall. NanoDelivery 2017_TP
NanoDelivery 2017_TPRiley Matthews
油
This document contains information about the International Conference and Exhibition on Nanomedicine and Drug Delivery that will take place from May 29-31, 2017 in Osaka, Japan. It includes the tentative program agenda, speaker biographies, organizing committee members, and registration information. The conference will feature keynote lectures, interactive sessions, workshops, and tracks on topics related to nanomedicine and drug delivery over the three-day event.Next Generation Dx Summit 2015 - Moving Assays to the Clinic
Next Generation Dx Summit 2015 - Moving Assays to the ClinicJames Prudhomme
油
The Next Generation Dx Summit, entering its seventh year, brings together more than 800 diagnostics professionals from across the world, providing comprehensive programming and valuable networking opportunities. Spanning from clinical diagnostics to business strategy, this years expanded program encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer immunotherapy, and reimbursement. With widespread coverage of all the most relevant diagnostics topics, the Next Generation Dx Summit promises to be a must-attend event to hear the latest announcements and developments in this rapidly evolving field.Seventh Annual Next Generation Dx Summit
Seventh Annual Next Generation Dx SummitJaime Hodges
油
The Next Generation Dx Summit (www.nextgenerationdx.com), entering its seventh year, brings together more than 800 diagnostics professionals from across the world, providing comprehensive programming and valuable networking opportunities. Spanning from clinical diagnostics to business strategy, this years expanded program encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer immunotherapy, and reimbursement. With widespread coverage of all the most relevant diagnostics topics, the Next Generation Dx Summit promises to be a must-attend event to hear the latest announcements and developments in this rapidly evolving field.Dr Viral Shah 
Dr Viral Shah drviral
油
Medical Director - Spectrum Healthcare(www.spectrumhealthcare.co.in), Chairman Medsphere Technologies Pvt. Ltd., Director- Exemplar Lifecare Pvt. Ltd (Cheenykum.com)
InKForge Launch Event - 17 January 2012 - The University of Sheffield
InKForge Launch Event - 17 January 2012 - The University of SheffieldCristina Staicu
油
Industrial Knowledge Forge partnering with industry to develop the next generation of research leaders - I was invited to participate at the event.resume update
resume updateLouis Cappelli
油
Louis Cappelli III is currently pursuing a Master's degree in Biomedical Sciences at Rowan University with a 4.0 GPA. He received his Bachelor's degree in Biology from Saint Joseph's University, graduating with a 3.37 GPA. He has extensive laboratory experience from internships at the USDA and Cooper University Hospital. His research includes projects developing water filtration systems for use in Africa and constructing a database of patients who underwent gamma knife procedures. He has leadership experience from involvement in various clubs and sports teams and works as a substitute teacher.30_Program Elective course - II (Radiology techniques).pdf
30_Program Elective course - II (Radiology techniques).pdfVamsi kumar
油
The elective course "Radiological Techniques" will provide medical lab technology students with an in-depth understanding of the role, principles, techniques, and applications of radiology. The course begins with an overview of the fundamentals of radiology and the principles of radiation physics. It then progresses to cover more advanced radiological techniques such as CT, MRI, Ultrasound, PET, and Mammography, and the interpretation of radiological images. The final part of the course will focus on specialized topics including interventional radiology and nuclear medicine. Through the course, students will be encouraged to analyze various case studies to enhance their understanding of practical applications of radiology.
Created by: Mr. Attuluri Vamsi Kumar, Assistant Professor, Department of MLT, UIAHS, Chandigarh University, Mohali, Punjab. For more details website: https://www.mltmaster.comThe Clinical Genome Conference 2014
The Clinical Genome Conference 2014Nicole Proulx
油
This year's 3rd Annual TCGC: The Clinical Genome Conference, held June 10-12, 2014 in San Francisco, is a three-day event that weaves together the science of sequencing and the business of implementing genomics in the clinic. It uniquely illustrates the mutual influence of those areas and the need to therefore consider the needs, challenges and opportunities of both - from next-generation sequencing and variant interpretation to insurance reimbursement and electronic health records - throughout the entire research process.Learn more at http://www.clinicalgenomeconference.comEmory Eye Tumor SPORE Update - Robin Noe, MD
Emory Eye Tumor SPORE Update - Robin Noe, MDMelanoma Research Foundation
油
The document summarizes an update on the Emory Eye Tumor SPORE (Specialized Programs of Research Excellence), which aims to advance research on ocular melanoma through collaboration between basic and clinical scientists. It describes the origins and goals of the SPORE program and the Emory Eye Tumor SPORE in particular. The Emory SPORE has added conjunctival malignant melanoma to its research focus. It provides details on the principal investigators, projects, and scoring of the SPORE grant application to the NIH, noting strengths in significance, innovation, investigators, and environment.SMi Group's 7th annual Advances in Cell Based Assays conference
SMi Group's 7th annual Advances in Cell Based Assays conferenceDale Butler
油
This document summarizes a two-day conference on advances in cell-based assays being held on November 11-12, 2014 in London. The conference will explore the latest developments in cell-based assays and their application in drug discovery and development. Speakers will include representatives from pharmaceutical companies such as GSK, AstraZeneca, Novartis, UCB, and Merck Serono, as well as academics. Topics will include the use of cell-based assays in biologics drug discovery, challenges in validation and regulation, phenotypic screening, stem cell technologies, and 3D cell cultures. Workshops on leveraging cell-based assays for open innovation and evaluating cell-based assays in drug discovery will also be offered3rd annual Tumour Models, London, UK
3rd annual Tumour Models, London, UKDiane McKenna
油
The number one aim of this year's Tumour Model London meeting is to improve the predictability and translatability of preclinical oncology research.Bryan Soper - resume
Bryan Soper - resumeBryan Soper
油
Bryan Soper has extensive experience in pharmaceutical competitive intelligence, medical writing, and data analysis. He currently performs contract work analyzing clinical trials and assessing drug approval likelihoods for Genentech. Previously he has analyzed cancer models and clinical trials to identify correlations. He holds a PhD in Molecular Biology from Cornell University and has worked as a postdoctoral scholar at UCSF investigating drug targets.Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...
Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...InsSilva801685
油
This document provides a table of contents for the book "Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics". The table of contents lists 50 chapters organized into 6 parts that cover topics such as principles of laboratory medicine, analytical techniques and instrumentation, analytes, pathophysiology, molecular diagnostics, and reference information.Marcus-Yaffee-Flier
- 1. Multimodal Imaging Probes For Research, Diagnostics and Therapeutics Presented by: Marcus Yaffee, PhD MPH Professional Senior Research Scientist Translational Imaging, USC When: Tuesday, AUGUST 11th, 2015 4:00 5:00 p.m. Where: HMRI Research Conference Center 734 Fairmount Avenue Pasadena, CA 91105 This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Institute for Medical Quality/California Medical Association (IMQ/CMA) through the joint providership of Huntington Hospital and Huntington Medical Research Institutes. The Huntington Hospital is accredited by the IMQ/CMA to provide continuing medical education for physicians. Huntington Hospital designates this live activity for a maximum of 1 hour of AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity. TOPIC SUMMARY: Development and validation of new imaging probes for biomedical research and clinical applications; design and synthesis of modular biocompatible mixed-metal nanoparticle [MMNP] composites for mutli-modal imaging. MMNP can be used for molecular targeted imaging and therapies, e.g. PET/MRI/CT. In vitro, in situ and in vivo case studies will be presented to demonstrate the function of each class of marker. ABOUT THE SPEAKER: Marcus Yaffee studied Chemistry at UNM, USA and the University of Cambridge, UK. He was awarded his PhD from the Swiss Federal Institute of Technology, Zurich and a professional MPH (Toxicology/EHS) at UC Berkeley (2006). He was Senior Scientist, Nuclear Medicine, University Hospital Bern, Switzerland (2012) , and is currently a research scientist in the group of Prof. Scott Fraser at the USC Translational Imaging Center. Dr. Yaffees professional skillsets include Synthetic Chemistry, Cell biology, Biophysics, Immunology and Toxicology as well as their clinical application. TARGET AUDIENCE: Clinicians and Researchers. LEARNING OBJECTIVES: 1. Gain knowledge of state-of-the-art and next generation imaging probes for diagnostics and therapeutics. 2. Understand clinical applications of theranostic probes. 3. Identify and design biomedical research studies using multimodal probes. 4. Understand clinical application of multiplexed probes in pathology.